Comparison between Patel Engineering FPO and Plethico Pharmaceuticals IPO.
Patel Engineering FPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Plethico Pharmaceuticals IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
| Patel Engineering FPO | Plethico Pharmaceuticals IPO | |
|---|---|---|
| Logo |  | |
| Issue Category | Mainboard | Mainboard |
| Issue Type | FPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | Enam Financial Consultants Pvt Ltd ICICI Securities Ltd. | |
| Registrar | MUFG Intime India Pvt.Ltd. | |
| Market Maker | ||
| DRHP | DRHP  | |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Patel Engineering FPO is up to ₹425.00 Cr whereas the issue size of the Plethico Pharmaceuticals IPO is up to ₹110.00 Cr. The final issue price of Patel Engineering FPO is ₹440.00 per share and of Plethico Pharmaceuticals IPO is ₹300.00 per share.
| Patel Engineering FPO | Plethico Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹10 per share |
| Issue Price (Lower) | ₹400.00 per share | ₹280.00 per share |
| Issue Price (Upper) | ₹440.00 per share | ₹300.00 per share |
| Issue Price (Final) | ₹440.00 per share | ₹300.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 96,59,090 shares | 36,66,667 shares |
| Fresh Issue Size (Amount) | up to ₹425.00 Cr | up to ₹110.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 96,59,090 shares | 36,66,667 shares |
| Issue Size Total (Amount) | up to ₹425.00 Cr | up to ₹110.00 Cr |
Patel Engineering FPO opens on May 03, 2006, while Plethico Pharmaceuticals IPO opens on Apr 10, 2006. The closing date of Patel Engineering FPO and Plethico Pharmaceuticals IPO is May 09, 2006, and Apr 17, 2006, respectively.
Patel Engineering FPO P/E ratio is , as compared to Plethico Pharmaceuticals IPO P/E ratio of .
| Patel Engineering FPO | Plethico Pharmaceuticals IPO | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 64.52 | 97.5 | ||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 54.07 | 87.01 | ||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||
| Market Cap | ₹2625.00 Cr. | ₹1022.00 Cr. | ||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||
| EPS | ₹7.80 | |||||||||||||||||||||||||
| RoNW | 27.46% | |||||||||||||||||||||||||
In the Patel Engineering FPO Retail Individual Investors (RII) are offered 32,11,648 shares while in Plethico Pharmaceuticals IPO retail investors are offered 32,11,648 shares. Qualified Institutional Buyers (QIB) are offered 45,88,066 shares in Patel Engineering FPO and 22,00,000 shares in Plethico Pharmaceuticals IPO.
| Patel Engineering FPO | Plethico Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 45,88,066 shares | 22,00,000 shares |
| NII | 13,76,421 shares | 3,66,667 shares |
| RII | 32,11,648 shares | 11,00,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 96,59,090 shares | 36,66,667 shares |
Patel Engineering FPO subscribed in total, whereas Plethico Pharmaceuticals IPO subscribed .
